Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cardiovasc Res ; 113(2): 134-146, 2017 02.
Article in English | MEDLINE | ID: mdl-28082453

ABSTRACT

AIMS: Obesity and type 2 diabetes (T2D) trigger a harmful stress-induced cardiac remodeling process known as cardiomyopathy. These diseases represent a serious and widespread health problem in the Western world; however the underlying molecular basis is not clear. ATF3 is an 'immediate early' gene whose expression is highly and transiently induced in response to multiple stressors such as metabolic, oxidative, endoplasmic reticulum and inflammation, stressors that are involved in T2D cardiomyopathy. The role of ATF3 in diabetic cardiomyopathy is currently unknown. Our research has aimed to study the effect of ATF3 expression on cardiomyocytes, heart function and glucose homeostasis in an obesity-induced T2D mouse model. METHODS AND RESULTS: We used wild type mice (WT) as well as mutant mice with a cardiac-specific ATF3 deficiency (ATF3-cKO). Mice were fed a high-fat diet (HFD) for 15 weeks. HFD induced high ATF3 expression in cardiomyocytes. Mice were examined for cardiac remodeling processes and the diabetic state was assessed. HFD-fed ATF3-cKO mice exhibited severe cardiac fibrosis, higher levels of heart hypertrophic markers, increased inflammation and worse cardiac function, as compared to WT mice. Interestingly, HFD-fed ATF3-cKO mice display increased hyperglycemia and reduced glucose tolerance, despite higher blood insulin levels, as compared to HFD-fed WT mice. Elevated levels of the cardiac inflammatory cytokines IL-6 and TNFα leading to impaired insulin signalling may partially explain the peripheral glucose intolerance. CONCLUSIONS: Cardiac ATF3 has a protective role in dampening the HFD-induced cardiac remodeling processes. ATF3 exerts both local and systemic effects related to T2D-induced cardiomyopathy. This study provides a strong relationship between heart remodeling processes and blood glucose homeostasis.


Subject(s)
Activating Transcription Factor 3/metabolism , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/blood , Diabetic Cardiomyopathies/blood , Myocytes, Cardiac/metabolism , Ventricular Remodeling , Activating Transcription Factor 3/deficiency , Activating Transcription Factor 3/genetics , Animals , Cardiomegaly/blood , Cardiomegaly/metabolism , Cardiomegaly/pathology , Cells, Cultured , Diabetes Mellitus, Type 2/etiology , Diabetic Cardiomyopathies/etiology , Diabetic Cardiomyopathies/pathology , Diabetic Cardiomyopathies/physiopathology , Diet, High-Fat , Disease Models, Animal , Fatty Acids, Nonesterified/pharmacology , Fibrosis , Genetic Predisposition to Disease , Homeostasis , Inflammation Mediators/metabolism , Insulin/blood , Integrases/genetics , Interleukin-6/blood , Mice, Inbred C57BL , Mice, Knockout , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/pathology , Myosin Heavy Chains/genetics , Phenotype , Promoter Regions, Genetic , Tumor Necrosis Factor-alpha/blood , Ventricular Remodeling/drug effects
2.
Anal Chem ; 87(18): 9459-66, 2015 Sep 15.
Article in English | MEDLINE | ID: mdl-26278590

ABSTRACT

We present a novel assay for rapid and high sensitivity detection of nucleic acids without amplification. Utilizing the neutral backbone of peptide nucleic acids (PNA), our method is based on the design of low electrophoretic mobility PNA probes, which do not focus under isotachophoresis (ITP) unless bound to their target sequence. Thus, background noise associated with free probes is entirely eliminated, significantly improving the signal-to-noise ratio while maintaining a simple single-step assay requiring no amplification steps. We provide a detailed analytical model and experimentally demonstrate the ability to detect targets as short as 17 nucleotides (nt) and a limit of detection of 100 fM with a dynamic range of 5 decades. We also demonstrate that the assay can be successfully implemented for detection of DNA in human serum without loss of signal. The assay requires 15 min to complete, and it could potentially be used in applications where rapid and highly sensitive amplification-free detection of nucleic acids is desired.


Subject(s)
DNA/analysis , DNA/chemistry , Isotachophoresis/methods , Nucleic Acid Hybridization/methods , Oligonucleotide Probes/chemistry , Peptide Nucleic Acids/chemistry , DNA/blood , DNA/isolation & purification , Humans , Limit of Detection , Signal-To-Noise Ratio , Time Factors
3.
Anal Chem ; 86(20): 10106-13, 2014 Oct 21.
Article in English | MEDLINE | ID: mdl-25158068

ABSTRACT

We present a novel microfluidic assay for continuous and quantitative detection of bacteria in water. We leverage isotachophoresis (ITP), an electrophoretic focusing technique, to create a stationary high concentration zone of fluorescently labeled antimicrobial peptides (AMPs) in a microfluidic channel. The tested water sample flows continuously through this high concentration AMPs reaction zone; any bacteria present in the sample is simultaneously labeled by, and separated from, the high concentration AMPs. The labeled bacteria continue into the downstream pure-buffer zone where the fluorescence signal is monitored, providing a direct quantitative measurement of the original bacterial concentration in the sample. We present the principles of the technique, demonstrate its applicability for quantitative detection of E. coli as well as its stability over a 1 h monitoring time, and provide a simple model for predicting its performance at different operating conditions. The method could be potentially expanded for use with other types of probes and provide continuous analysis and monitoring of water samples at the point of need.


Subject(s)
Anti-Infective Agents/chemistry , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Isotachophoresis/methods , Microfluidics/methods , Peptides/chemistry , Spectrometry, Fluorescence
SELECTION OF CITATIONS
SEARCH DETAIL
...